Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/13/16 → 5/12/18 |
Funding
- PPD Investigator Services LLC: $17,199.00
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined with Bevacizumab vs. Bevacizumab Monotherapy in Patients with Recurrent Glioblastoma
- Villano, PhD, John (PI)
- Thind, Ravneet (CoI)